$RTON

RIGHT ON BRANDS INC

Offices and clinics of medical doctors · OTCID

0.023 -49.33% as of 10/30/2026, 3:01:15 PM · delayed

Sentiment

BULLISH BEARISH

No open positions yet.

No threads yet for $RTON. Be the first to post.

Official links

Filings

15-12G Tue Oct 15 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
8-K Thu Jul 25 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
8-K Tue Jul 16 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
8-K Fri Jul 12 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
NT 10-K Tue Jul 02 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
10-Q Mon Apr 15 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
8-K Fri Mar 01 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
NT 10-Q Thu Feb 15 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov

All filings

Timeline

revenue 9/8/2026 Revenue reported: $1.14M, year ended Mar 31, 2023
revenue 9/8/2026 Revenue reported: $406.0K, quarter ended Jun 30, 2023
import 9/7/2026 RTON added from OTCID universe
filing 10/14/2024 15-12G filed
filing 7/24/2024 8-K filed
filing 7/15/2024 8-K filed
filing 7/11/2024 8-K filed
filing 7/1/2024 NT 10-K filed
filing 4/14/2024 10-Q filed
filing 2/29/2024 8-K filed

Company reliability

–

No resolved statements yet.

Revenue

Quarterly

Jun 2023 $406K

Annual

FY 2023 $1.1M

Source: SEC XBRL

CEO compensation

$72K (FY 2023) · 0.1x revenue

All disclosed CEO pay: $326K since 2016 (may span more than one CEO)

10-K

Provisional - extracted from filings, not verified.

FY 2022 $17K extracted
FY 2021 $17K extracted

Notes & debt

Provisional - extracted from filings, not verified.

IN DEFAULT · $364K in arrears (+1 with unknown amounts)
$50K matured Feb 20, 2020 10-Q · 2024-04-15

Quote

On November 22, 2019, the Company issued a $50,000 promissory note to an individual for a $25,000 cash borrowing.
— matured Feb 20, 2020 10-Q · 2024-04-15

Quote

During December 2021, the Company was listed as defendant on a complaint from Noteholder 10 seeking repayment of amounts due under a February 2020 convertible note payable.
$61K matured Dec 31, 2022 10-Q · 2024-04-15

Quote

On August 11, 2022, the Company entered into a 12 % note payable agreement totaling $ 60,760 , consisting of cash proceeds totaling $ 50,000 , financing costs of $ 4,250 , and an original discount totaling $ 6,510 .
$84K matured Aug 11, 2023 12% 10-Q · 2024-04-15

Quote

On June 22, 2023, the Company entered into a 12 % note payable agreement totaling $ 84,000 , consisting of cash proceeds totaling $ 63,195 , financing costs of $ 5,000 , an original discount totaling $ 9,000 , and accrued interest from the August 11, 2022 note totaling $ 6,805 .
$90K matured Jan 21, 2024 10-Q · 2024-04-15

Quote

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) On July 21, 2022, the Company entered into a note payable agreement totaling $ 89,581 , consisting of cash proceeds totaling $ 72,101 , repayment of the January 31, 2022 loan balance totaling $6,999, and loan fees totaling $ 10,481 .
$80K matured Jan 21, 2024 10-Q · 2024-04-15

Quote

On August 4, 2022, the Company entered into a note payable agreement for $ 80,000 received as advances during the three months ended June 30, 2022.
NEARING / AGED
$0 — 5.26% 10-Q · 2024-04-15

Quote

At December 31, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in note payable agreements based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $ 0.0118 ; risk-free interest rates ranging from 5.26 % to 5.40 %, and expected volatility of the Company’s common stock ranging from 337 % to 411 %, estimated exercise prices ranging from $ 0.003 to $ 0.025 , and terms under one year.
— — 10-Q · 2024-04-15

Quote

On October 16, 2023, the Company issued a convertible note payable agreement that included a conversion feature meeting the definition of a derivative liability which therefore required bifurcation.
— — 10-Q · 2024-04-15

Quote

On June 22, 2023, the Company issued a note payable agreement which contained default provisions that included a conversion feature meeting the definition of a derivative liability which therefore required bifurcation.
OTHER ISSUANCES
$105K — 10-Q · 2024-04-15

Quote

Cash Flows – Financing Activities For the nine months ended December 31, 2023, our cash provided by financing activities amounted to approximately $77,000, which includes approximately $63,000 in proceeds from notes payable, $105,000 in proceeds from convertible notes payable, and repayments of notes payable totaling approximately $91,000.
No notes match this filter.

Top predictors

No resolved predictions on $RTON yet.

Upcoming resolutions

Nothing awaiting resolution.